FDA Restricts Johnson & Johnson’s COVID-19 Vaccine Due to Blood Clot Risk
US regulators strictly limit who can receive Johnson & Johnson’s COVID vaccine over rare but serious blood clots risk.
US regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.
Check Tweet:
(SocialLY brings you all the latest breaking news, viral trends and information from social media world, including Twitter, Instagram and Youtube. The above post is embeded directly from the user's social media account and LatestLY Staff may not have modified or edited the content body. The views and facts appearing in the social media post do not reflect the opinions of LatestLY, also LatestLY does not assume any responsibility or liability for the same.)
Tags
blood clot
Blood Clot Risk
Breaking News
Coronavirus
COVID 19
COVID-19 Vaccine
Disclose TV News
Disclose TV Tweets
FDA
global news
Johnson & Johnson
Johnson & Johnson COVID-19 Vaccine
Johnson & Johnson's
Johnson & Johnson’s COVID-19 Vaccine
Latest News
Live Breaking News Headlines
US
us news
world news